Reference
Topiramate (Topamax): start of safety review triggered by a study reporting an increased risk of neurodevelopmental disabilities in children with prenatal exposure Internet Document : 1 Aug 2022. Available from: URL: https://www.gov.uk/drug-safety-update/topiramate-topamax-start-of-safety-review-triggered-by-a-study-reporting-an-increased-risk-of-neurodevelopmental-disabilities-in-children-with-prenatal-exposure
Rights and permissions
About this article
Cite this article
Topiramate prenatal exposure: risk of neurodevelopmental disabilities. Reactions Weekly 1918, 8 (2022). https://doi.org/10.1007/s40278-022-20465-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-20465-8